ONCONETIX INC (ONCO) Fundamental Analysis & Valuation

NASDAQ:ONCO • US68237Q2030

Current stock price

1.22 USD
+0.09 (+7.96%)
At close:
1.1 USD
-0.12 (-9.84%)
After Hours:

This ONCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ONCO Profitability Analysis

1.1 Basic Checks

  • ONCO had negative earnings in the past year.
  • ONCO had a negative operating cash flow in the past year.
  • In the past 5 years ONCO always reported negative net income.
  • In the past 5 years ONCO always reported negative operating cash flow.
ONCO Yearly Net Income VS EBIT VS OCF VS FCFONCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • ONCO has a worse Return On Assets (-62.31%) than 60.93% of its industry peers.
  • Looking at the Return On Equity, with a value of -98.51%, ONCO is in line with its industry, outperforming 44.29% of the companies in the same industry.
Industry RankSector Rank
ROA -62.31%
ROE -98.51%
ROIC N/A
ROA(3y)-104.68%
ROA(5y)-99.32%
ROE(3y)-258.38%
ROE(5y)-222.83%
ROIC(3y)N/A
ROIC(5y)N/A
ONCO Yearly ROA, ROE, ROICONCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • ONCO's Gross Margin of 77.63% is amongst the best of the industry. ONCO outperforms 83.95% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ONCO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONCO Yearly Profit, Operating, Gross MarginsONCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ONCO Health Analysis

2.1 Basic Checks

  • ONCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ONCO has been increased compared to 1 year ago.
  • Compared to 5 years ago, ONCO has more shares outstanding
  • ONCO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ONCO Yearly Shares OutstandingONCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100K 200K 300K
ONCO Yearly Total Debt VS Total AssetsONCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -8.06, we must say that ONCO is in the distress zone and has some risk of bankruptcy.
  • ONCO's Altman-Z score of -8.06 is on the low side compared to the rest of the industry. ONCO is outperformed by 70.21% of its industry peers.
  • There is no outstanding debt for ONCO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.06
ROIC/WACCN/A
WACC13.12%
ONCO Yearly LT Debt VS Equity VS FCFONCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • ONCO has a Current Ratio of 0.66. This is a bad value and indicates that ONCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.66, ONCO is doing worse than 90.14% of the companies in the same industry.
  • ONCO has a Quick Ratio of 0.66. This is a bad value and indicates that ONCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.65, ONCO is not doing good in the industry: 89.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.65
ONCO Yearly Current Assets VS Current LiabilitesONCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ONCO Growth Analysis

3.1 Past

  • ONCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.14%, which is quite impressive.
  • ONCO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.70%.
EPS 1Y (TTM)99.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.14%
Revenue 1Y (TTM)-67.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.36%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ONCO Yearly Revenue VS EstimatesONCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ONCO Yearly EPS VS EstimatesONCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -1K -2K -3K -4K

More info and screens

Find the best growth stocksShow best growing peers

0

4. ONCO Valuation Analysis

4.1 Price/Earnings Ratio

  • ONCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONCO Price Earnings VS Forward Price EarningsONCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONCO Per share dataONCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ONCO Dividend Analysis

5.1 Amount

  • No dividends for ONCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONCO Fundamentals: All Metrics, Ratios and Statistics

ONCONETIX INC

NASDAQ:ONCO (4/9/2026, 8:00:03 PM)

After market: 1.1 -0.12 (-9.84%)

1.22

+0.09 (+7.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)06-01
Inst Owners4.14%
Inst Owner Change0%
Ins Owners0.63%
Ins Owner Change0%
Market Cap4.37M
Revenue(TTM)815.30K
Net Income(TTM)-15.53M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.36
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-38.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.7
FCFYN/A
OCF(TTM)-2.7
OCFYN/A
SpS0.23
BVpS4.4
TBVpS-0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.31%
ROE -98.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.63%
FCFM N/A
ROA(3y)-104.68%
ROA(5y)-99.32%
ROE(3y)-258.38%
ROE(5y)-222.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.65
Altman-Z -8.06
F-Score5
WACC13.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.79%
OCF growth 3YN/A
OCF growth 5YN/A

ONCONETIX INC / ONCO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ONCONETIX INC (ONCO) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ONCO.


What is the valuation status of ONCONETIX INC (ONCO) stock?

ChartMill assigns a valuation rating of 0 / 10 to ONCONETIX INC (ONCO). This can be considered as Overvalued.


What is the profitability of ONCO stock?

ONCONETIX INC (ONCO) has a profitability rating of 1 / 10.


How financially healthy is ONCONETIX INC?

The financial health rating of ONCONETIX INC (ONCO) is 4 / 10.